176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.87%
Revenue growth above 1.5x INTC's 2.42%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
16.24%
Gross profit growth above 1.5x INTC's 5.92%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
98.75%
EBIT growth above 1.5x INTC's 6.74%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
98.75%
Operating income growth above 1.5x INTC's 6.74%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
85.51%
Net income growth above 1.5x INTC's 22.96%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
76.92%
EPS growth above 1.5x INTC's 24.24%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
76.92%
Diluted EPS growth above 1.5x INTC's 25.00%. David Dodd would see if there's a robust moat protecting these shareholder gains.
6.88%
Slight or no buybacks while INTC is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
2.71%
Diluted share change of 2.71% while INTC is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
22750.46%
Positive OCF growth while INTC is negative. John Neff would see this as a clear operational advantage vs. the competitor.
696.01%
Positive FCF growth while INTC is negative. John Neff would see a strong competitive edge in net cash generation.
273.40%
10Y revenue/share CAGR above 1.5x INTC's 166.96%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
273.40%
5Y revenue/share CAGR above 1.5x INTC's 31.31%. David Dodd would look for consistent product or market expansions fueling outperformance.
13.59%
3Y revenue/share CAGR under 50% of INTC's 56.47%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
1483.66%
10Y OCF/share CAGR above 1.5x INTC's 147.49%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
1483.66%
5Y OCF/share CAGR above 1.5x INTC's 23.65%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
108.29%
3Y OCF/share CAGR above 1.5x INTC's 16.31%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
178.31%
Net income/share CAGR at 50-75% of INTC's 239.12%. Martin Whitman might question if the firm’s product or cost base lags behind.
178.31%
5Y net income/share CAGR above 1.5x INTC's 25.30%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-34.16%
Negative 3Y CAGR while INTC is 156.81%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
700.35%
10Y equity/share CAGR above 1.5x INTC's 257.23%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
700.35%
5Y equity/share CAGR above 1.5x INTC's 8.59%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
54.06%
3Y equity/share CAGR above 1.5x INTC's 12.03%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.62%
Firm’s AR is declining while INTC shows 4.43%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
6.04%
Inventory growth well above INTC's 11.05%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.77%
Asset growth above 1.5x INTC's 2.01%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-0.54%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-37.06%
We’re deleveraging while INTC stands at 253.65%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-4.35%
Our R&D shrinks while INTC invests at 1.57%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
4.99%
SG&A growth well above INTC's 8.66%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.